Back to Search
Start Over
Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
- Source :
-
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 01; Vol. 24 (23), pp. 6098. - Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 1557-3265
- Volume :
- 24
- Issue :
- 23
- Database :
- MEDLINE
- Journal :
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Publication Type :
- Academic Journal
- Accession number :
- 30510087
- Full Text :
- https://doi.org/10.1158/1078-0432.CCR-18-3340